Monthly Cost Breakdown: Wegovy vs Mounjaro Pricing Reality
Is Wegovy Safer Than Mounjaro: Understanding Monthly Cost Implications
The question of whether is Wegovy safer than Mounjaro extends beyond clinical profiles to practical affordability over months and years of treatment. Wegovy's monthly costs follow a structured escalation from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose. This predictable pricing structure allows patients to budget effectively for their weight management journey. Mounjaro follows a different dosing schedule with varying cost implications, making direct monthly comparisons essential for treatment planning.
Both medications require long-term commitment, as clinical evidence shows weight regain occurs when treatment stops. The STEP 1 extension trial demonstrated patients regained approximately two-thirds of weight lost within one year of discontinuing Wegovy. Understanding monthly costs becomes crucial when considering this as a sustained treatment rather than a short-term intervention. Your prescriber can help determine which option aligns with both your clinical needs and financial planning.
Wegovy Pricing Structure: Complete Monthly Cost Breakdown
When evaluating is Wegovy safer than Mounjaro from a cost perspective, Wegovy's transparent pricing follows the mandatory dose escalation protocol. Month 1-4 costs £79.99 for 0.25mg (with code FIRST40 for new customers), months 5-8 cost £94.99 for 0.5mg, months 9-12 cost £99.99 for 1mg, and months 13-16 cost £139.99 for 1.7mg. From month 17 onwards, the maintenance 2.4mg dose costs £209.99 monthly. Returning customers benefit from code DOSE25 applied at checkout to reach these final prices.
Our Getting Started bundles provide convenience for consecutive doses: the Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks in one order. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 covers months 5-16, while the Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99. These bundles ensure treatment continuity without the need for multiple monthly orders during your escalation phase.
Clinical Evidence: Wegovy Safety Profile vs Mounjaro
In clinical trials, Wegovy demonstrated its safety profile across the comprehensive STEP programme, with STEP 1 showing ~15% average weight loss at 68 weeks alongside diet and exercise, compared to ~2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial confirmed ~clinically studied weight loss sustained at 2 years, while SELECT showed a 20% reduction in major cardiovascular events. These trials enrolled over 4,500 participants across various populations, providing robust safety data for the semaglutide mechanism.
Mounjaro's clinical programme focused on the dual GIP/GLP-1 approach with different trial designs and populations, making direct safety comparisons challenging without head-to-head studies. Both medications carry MHRA additional monitoring status (Black Triangle ▼) as newer treatments requiring ongoing safety surveillance. Your prescriber will evaluate your individual risk factors, medical history, and treatment goals when determining which option may be more suitable for your circumstances.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your natural fullness hormone to reduce appetite and promote satiety after smaller meals. This mechanism works on brain appetite centres, potentially reducing food cravings and helping you feel satisfied with less food. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy focuses exclusively on GLP-1 pathways, providing a well-established mechanism with extensive clinical experience. The once-weekly injection via FlexTouch pen delivers consistent medication levels between doses. This targeted approach has been studied extensively across multiple populations, from adults with obesity to those with type 2 diabetes in the STEP 2 trial showing ~clinically studied weight loss.
Ordering Process: From Assessment to Delivery
Whether you're considering is Wegovy safer than Mounjaro, our ordering process ensures clinical safety through proper medical oversight. Complete our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Your application undergoes prescriber review within 3 working days (or 24 hours with express service), where qualified clinicians evaluate suitability based on MHRA licensing criteria including BMI ≥30 or BMI ≥27 with weight-related comorbidity. Once approved, we dispatch your Wegovy via next-day cold-chain delivery maintaining the required 2-8°C temperature throughout transport. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK regulatory standards for this prescription-only medicine.
Storage and Practical Considerations for Long-term Use
Wegovy requires refrigeration at 2-8°C before first use, but offers a practical advantage with 6 weeks of room temperature storage below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen system provides consistent dosing through the mandatory escalation schedule: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance. Each pen contains 4 weekly doses, making monthly ordering straightforward with our bundle options. Store unused pens in their original carton to protect from light, and never freeze or shake the medication. This 6-week room temperature advantage makes Wegovy more suitable for travel or temporary storage situations during your long-term treatment journey.
Long-term Cost Planning: Annual Wegovy vs Mounjaro Investment
When determining is Wegovy safer than Mounjaro from a financial commitment perspective, calculating annual costs helps inform treatment decisions. Wegovy's maintenance dose (2.4mg) costs £209.99 monthly, totaling £2,519.88 annually at maintenance level. However, your first year includes the 16-week dose escalation at lower costs: approximately £1,244.96 for months 1-12, then £2,519.88 annually thereafter. These figures assume optimal dosing without treatment interruptions or dose adjustments.
Compare this to potential Mounjaro costs and consider the value of Wegovy's established clinical evidence, longer room temperature storage, and extensive real-world experience since UK launch. Both treatments represent significant financial commitments reflecting their status as innovative prescription-only medicines requiring ongoing medical supervision. Your prescriber can discuss whether either treatment's clinical benefits justify the long-term investment based on your individual circumstances and weight management goals.
Making Your Treatment Decision: Wegovy and Mounjaro Available
Rather than definitively answering is Wegovy safer than Mounjaro, the choice depends on your individual medical profile, cost considerations, and prescriber recommendations. At EverydayMeds, both treatments are available following clinical assessment, allowing your prescriber to recommend the most appropriate option based on current clinical guidelines and your specific needs. Our transparent pricing structure for Wegovy, combined with discount codes FIRST40 for new customers and DOSE25 for returning patients, ensures predictable monthly costs throughout your treatment journey. Contact our clinical team through the online assessment to discuss which prescription weight management treatment aligns with your health goals and budget planning. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
